Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,817–3,824 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Sanofi Capeserod Gastrointestinal (GI) indications Phase 2 Trial Planned Oral Gastroenterology
Sanofi VG-3927 Alzheimer's disease Phase 2 Trial Planned Oral Neurology
Sanofi SAR4442454, BNT111 and LIBTAYO (cemiplimab) Melanoma Phase 2 Data Released SAR4442454: Intravenous BNT111: Intravenous LIBTAYO (cemiplimab): Intravenous Oncology
Sanofi VGL101 - (ILLUMINATE) Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Phase 2 Ongoing Intravenous Neurology
Sanofi Amcenestrant - (AMEERA-3) Breast Cancer Phase 2 Trial Completed Oral Oncology
Sanofi Pegenzileukin (THOR-707) and KEYTRUDA (pembrolizumab) Solid tumors Phase 2 Ongoing Intravenous Oncology
Sanofi KT-474 (SAR444656) - (ADVANTA) Hidradenitis suppurativa / atopic dermatitis Phase 2 Trial Discontinued oral Immunology
Sanofi DNL788 (SAR443820) Multiple sclerosis Phase 2 Trial Discontinued Oral Neurology